RINALDI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.625
EU - Europa 535
AS - Asia 272
AF - Africa 64
SA - Sud America 50
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.547
Nazione #
US - Stati Uniti d'America 1.624
IT - Italia 94
SG - Singapore 90
UA - Ucraina 85
IE - Irlanda 78
SE - Svezia 76
RU - Federazione Russa 72
HK - Hong Kong 64
CI - Costa d'Avorio 55
CN - Cina 55
BR - Brasile 49
DE - Germania 45
TR - Turchia 34
FI - Finlandia 24
DK - Danimarca 23
FR - Francia 14
GB - Regno Unito 14
KR - Corea 13
IN - India 9
MA - Marocco 7
BE - Belgio 3
NL - Olanda 3
IL - Israele 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
PL - Polonia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.547
Città #
Chandler 236
Fairfield 168
Ashburn 154
Jacksonville 134
Dublin 78
Seattle 77
Wilmington 71
Woodbridge 67
Boardman 65
Hong Kong 64
Houston 64
New York 60
Des Moines 57
Abidjan 55
Singapore 55
Cambridge 50
Ann Arbor 31
Lawrence 30
Princeton 30
San Mateo 29
Turin 21
Los Angeles 17
Washington 17
Moscow 15
San Diego 13
Helsinki 12
Norwalk 8
Shanghai 8
The Dalles 7
Beijing 6
Dallas 6
Pune 6
Ancona 5
Falls Church 5
Rio de Janeiro 5
Saint Louis 5
Santa Clara 4
Castelraimondo 3
Guangzhou 3
Jiaxing 3
Kilburn 3
London 3
Montegiorgio 3
São Paulo 3
Wuhan 3
Brussels 2
Chengdu 2
Chennai 2
Chicago 2
Hounslow 2
Munich 2
Santo Antônio da Patrulha 2
Sassari 2
Wuxi 2
Acquaviva Picena 1
Alfenas 1
Andrelândia 1
Ankara 1
Aversa 1
Baghdad 1
Baku 1
Belo Horizonte 1
Betim 1
Bevagna 1
Bishkek 1
Brooklyn 1
Campina Grande 1
Campos dos Goytacazes 1
Canary Wharf 1
Capão do Leão 1
Casablanca 1
Catalão 1
Cesena 1
Charlotte 1
Chiswick 1
Concórdia 1
Curitiba 1
Curvelo 1
Darling 1
Devoto 1
Diadema 1
Divinópolis 1
Engenheiro Caldas 1
Estância Velha 1
Friesland 1
Guarulhos 1
Harrison 1
Ho Chi Minh City 1
Hortolândia 1
Iapu 1
Iporá 1
Islington 1
Jianning 1
Lagoa Santa 1
Lanzhou 1
Liège 1
Maceió 1
Marche 1
Marrakesh 1
Miami 1
Totale 1.823
Nome #
The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis 135
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 119
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 116
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 98
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 95
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 94
Electrolyte disorders in cancer patients: a systematic review 94
Managing hyponatremia in lung cancer: latest evidence and clinical implications 93
Hyponatremia in cancer patients: Time for a new approach 91
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 90
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 90
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 89
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 89
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 88
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 87
Systemic treatment for lung carcinoids: from bench to bedside 85
High CTLA-4 expression correlates with poor prognosis in thymoma patients 85
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 83
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 81
The Formidable Metamorphosis of the Salamander’s Wool: Asbestos from Eternal Material to Awful Pathologies 80
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 79
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 79
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 79
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 76
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 76
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 76
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 69
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 68
Lung cancer prognosis: Can histological patterns and morphological features have a role in the management of lung cancer patients? 66
Treatment of advanced small cell lung cancer 59
Totale 2.609
Categoria #
all - tutte 14.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 0 0 0 0 0 20 52
2020/2021620 40 62 61 2 126 34 51 74 45 44 46 35
2021/2022228 17 34 16 1 4 25 7 14 19 26 26 39
2022/2023622 34 86 36 72 20 113 0 43 142 0 61 15
2023/2024371 52 7 32 14 49 110 4 41 0 15 0 47
2024/2025473 84 49 16 3 36 31 56 26 102 37 33 0
Totale 2.609